JPMorgan raised the firm’s price target on Bath & Body Works to $39 from $35 and keeps a Neutral rating on the shares. The company reported in-line Q3 results and management raised its Q4 earnings outlook by 2% at the midpoint, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target raised to $36 from $35 at Piper Sandler
- Bath & Body Works price target raised to $49 from $48 at Morgan Stanley
- Bath & Body Works price target raised to $38 from $32 at Wells Fargo
- Bath & Body Works price target raised to $52 from $51 at Deutsche Bank
- Bath & Body Works price target raised to $34 from $28 at Barclays